Literature DB >> 25211431

The efficacy of psychotherapy: focus on psychodynamic psychotherapy as an example.

Kenneth N Levy, Johannes C Ehrenthal, Frank E Yeomans, Eve Caligor.   

Abstract

The growing number of individuals seeking treatment for mental disorders calls for intelligent and responsible decisions in health care politics. However, the current relative decrease in reimbursement of effective psychotherapy approaches occurring in the context of an increase in prescription of psychotropic medication lacks a scientific base. Using psychodynamic psychotherapy as an example, we review the literature on meta-analyses and recent outcome studies of effective treatment approaches. Psychodynamic psychotherapy is an effective treatment for a wide variety of mental disorders. Adding to the known effectiveness of other shorter treatments, the results indicate lasting change in many cases, especially for complex and difficult to treat patients, ultimately reducing health-care utilization. Research-informed health care decisions that take into account the solid evidence for the effectiveness of psychotherapy, including psychodynamic psychotherapy, have the potential to promote choice, increase mental health, and reduce society's burden of disease in the long run.

Entities:  

Mesh:

Year:  2014        PMID: 25211431     DOI: 10.1521/pdps.2014.42.3.377

Source DB:  PubMed          Journal:  Psychodyn Psychiatry        ISSN: 2162-2590


  3 in total

1.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United States.

Authors:  Matthew C Lohman; Karen L Whiteman; Frank E Yeomans; Sheila A Cherico; Winifred R Christ
Journal:  Psychiatr Serv       Date:  2016-10-03       Impact factor: 3.084

Review 3.  Moving Forward While Standing Still: A Case of Mental Health Advocacy Evolving in the Time of COVID-19.

Authors:  Renata M Villela; Susan G Lazar
Journal:  J Psychiatr Pract       Date:  2021-03-05       Impact factor: 1.841

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.